Faculty

Julia Rotow

MD
Clinical Director Thoracic Oncology
Dana-Farber Cancer Institute

Dr. Rotow received her MD from the UCLA David Geffen School of Medicine. She completed her residency training in Internal Medicine at the Massachusetts General Hospital and her fellowship training in Hematology/Oncology at the University of California, San Francisco. She is an Assistant Professor at Harvard Medical School and the clinical director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, where her research interests include the development of targeted therapies and immunotherapies for the treatment of oncogene-driven lung cancer.

2026 Sessions

Precision Treatment Pathways in NSCLC: Navigating Rare and Actionable Mutations

Supported by an educational grant from Revolution Medicines, Inc.

Presenter

Sunday, September 27 10:50–11:35 AM
Room Soho Complex - Gramercy/Herald
Faculty

Julia Rotow

MD
Clinical Director Thoracic Oncology
Dana-Farber Cancer Institute

Dr. Rotow received her MD from the UCLA David Geffen School of Medicine. She completed her residency training in Internal Medicine at the Massachusetts General Hospital and her fellowship training in Hematology/Oncology at the University of California, San Francisco. She is an Assistant Professor at Harvard Medical School and the clinical director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, where her research interests include the development of targeted therapies and immunotherapies for the treatment of oncogene-driven lung cancer.

Back to top